CORBUS PHARMACEUTICALS HLDGS's ticker is and the CUSIP is 21833P953. A total of 2 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1 | -100.0% | 16,300 | +2.5% | 0.00% | – |
Q3 2022 | $2,000 | -71.4% | 15,900 | -46.3% | 0.00% | – |
Q2 2022 | $7,000 | -53.3% | 29,600 | -1.3% | 0.00% | – |
Q1 2022 | $15,000 | -59.5% | 30,000 | -50.7% | 0.00% | – |
Q4 2021 | $37,000 | -91.5% | 60,900 | -74.6% | 0.00% | – |
Q3 2021 | $437,000 | -0.5% | 240,200 | 0.0% | 0.00% | – |
Q2 2021 | $439,000 | +470.1% | 240,200 | +61332.2% | 0.00% | – |
Q1 2021 | $77,000 | +126.5% | 391 | +40.6% | 0.00% | – |
Q4 2020 | $34,000 | -93.1% | 278 | -89.9% | 0.00% | -100.0% |
Q3 2020 | $494,000 | -71.9% | 2,748 | +31.2% | 0.00% | -66.7% |
Q2 2020 | $1,757,000 | +2124.1% | 2,095 | +1287.4% | 0.00% | – |
Q1 2020 | $79,000 | -40.6% | 151 | -38.4% | 0.00% | – |
Q4 2019 | $133,000 | +454.2% | 245 | +380.4% | 0.00% | – |
Q3 2019 | $24,000 | -56.4% | 51 | -36.2% | 0.00% | – |
Q1 2019 | $55,000 | -47.1% | 80 | -55.3% | 0.00% | – |
Q4 2018 | $104,000 | +205.9% | 179 | +289.1% | 0.00% | – |
Q3 2018 | $34,000 | +3300.0% | 46 | +2200.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 2 | -84.6% | 0.00% | – |
Q1 2018 | $1,000 | -50.0% | 13 | -71.1% | 0.00% | – |
Q4 2017 | $2,000 | -50.0% | 45 | -60.9% | 0.00% | – |
Q3 2017 | $4,000 | -60.0% | 115 | -17.3% | 0.00% | – |
Q2 2017 | $10,000 | -23.1% | 139 | -27.6% | 0.00% | -100.0% |
Q1 2017 | $13,000 | -72.3% | 192 | -61.8% | 0.00% | -66.7% |
Q4 2016 | $47,000 | – | 503 | +9960.0% | 0.00% | – |
Q3 2016 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 34,800 | $36,000 | 0.00% |
SIMPLEX TRADING, LLC | 240,200 | $437,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |